Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases

Simple item page
dc.contributor.authorAJ Martí-Carvajal
dc.contributor.authorPI Martí-Carvajal
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:17:59Z
dc.date.available2026-03-22T21:17:59Z
dc.date.issued2004
dc.description.abstractThis is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of human recombinant factor VIIa for patients with liver disease and upper gastrointestinal bleeding.
dc.identifier.doi10.1002/14651858.cd004887
dc.identifier.urihttps://doi.org/10.1002/14651858.cd004887
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/87113
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofCochrane Database of Systematic Reviews
dc.sourceUniversity of Carabobo
dc.subjectUpper gastrointestinal bleeding
dc.subjectRecombinant DNA
dc.subjectMedicine
dc.subjectGastrointestinal bleeding
dc.subjectGastroenterology
dc.subjectLiver disease
dc.subjectIntervention (counseling)
dc.subjectFactor VIIa
dc.subjectInternal medicine
dc.titleHuman recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases
dc.typereference-entry

Files

Collections

Otros